Riya Mishra
Global AI in Drug Discovery Industry was valued at US$ 281 million in 2019 and is expected to reach US$ 1597.02 million by 2030, growing at a CAGR of 35.64% over the forecast period. The rising use of artificial intelligence (AI) systems aimed at reducing the overall cost of drug discovery and improving outcomes is expected to boost demand for these platforms in the pharmaceutical industry. Artificial intelligence for drug discovery is a technology that uses and adds value to various algorithms in drug discovery during decision-making processes. In recent years, the increasing need to reduce the cost of new drug development and production is expected to strengthen the market for artificial intelligence (AI) platforms in the field of drug discovery. The estimated novel drug discovery and production cost is USD 2.6 billion, according to industry journals. This is largely due to the small development research funnel that excludes much of the preclinical and phase 1 study candidate therapies. As a result, major players in the pharmaceutical industry has started the adoption of artificial intelligence for a quicker, more reliable, and cost-effective drug development.
Access the Full Report @ https://www.absolutemarketsinsights.com/reports/AI-in-Drug-Discovery-2020---2028-731
The detailed research study provides qualitative and quantitative analysis of AI in Drug Discovery market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Key Findings of the Report:
- In the therapeutic area oncology segment will exhibit significant CAGR over the period. In the early detection of cancer, AI already plays a crucial role. In addition, as cancer treatments for each patient can differ, personalized medicine has proven to be an effective cancer treatment alternative. Oncologists are aided by artificial intelligence platforms designed to classify genetic mutations to design successful personalized patient care.
- Infectious diseases segment is also expected to expand over the period, large amounts of sample data is being needed by the AI platforms to begin identifying key trends and points. In infectious disease diagnostics and treatment design, the adoption of AI systems has begun to develop and is expected to experience robust growth in the coming years.
- North America dominated the market because of the growing adoption of artificial intelligence and the existence of a large number of market players.
- Over the forecast era, Asia Pacific is projected to emerge as the fastest-growing region in the sector. It is anticipated that the increasing adoption of new technologies in India and China for new drug production and an emphasis on improving pharmaceutical capability within countries would drive the market in this region.
- The major players operating in the market are Atomwise, Inc, BenevolentAI Ltd, BERG LLC, BIOAGE, Cloud Pharmaceuticals, Inc., DEEP GENOMICS, Envisagenics, EVAXION BIOTECH A/S, Exscientia, Google LLC, HACARUS INC, IBM Corp, Insilico Medicine, Microsoft, NuMedii, Inc., OWKIN, INC., twoXAR, Incorporated, VERGE genomics, XtalPi Inc., Cyclica and Other Market Participants.
AI in Drug Discovery Market:
By Drug Type
- Small Molecule
- Large Molecule
By Technology
- Deep Learning
- Machine Learning
- Others
By Application
- Target Identification and Validation
- Drugs Design and Redesign
- Preclinical Testing
- Others
By Organization Size
- Small and Medium Organizations
- Large Organizations
By Therapeutic Area
- Cardiovascular Disease
- Metabolic Disease
- Neurodegenerative Diseases
- Dermatological Diseases
- Infectious Diseases
- Oncology
- Others
By End Users
- Pharmaceutical Companies
- Research Centers and Laboratories
- Clinicians and Drug Developers
- Others
By Geography
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: [email protected]
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
0
Riya Mishra
Related Articles
The ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY marketing report assists in determining and optimizing each stage in the lifecycle of industrial process that includes engagement, acquisition, retention, and monetization. dbmr=global-artificial-intelligence-ai-in-drug-discovery-marketArtificial Intelligence (AI) in Drug Discovery Market Analysis and InsightsArtificial Intelligence (AI) is expected to be a lucrative technology in the healthcare industry. END USEPharmaceutical & Biotechnology CompaniesContract Research Organizations (CROs)Research Centres And Academic InstitutesOthersGlobal Artificial Intelligence (AI) in Drug Discovery Market Regional Analysis/InsightsThe countries covered in this market report are U. Global Artificial Intelligence (AI) in Drug Discovery Market Share AnalysisGlobal Artificial Intelligence (AI) in drug discovery market competitive landscape provides details by competitor. The above data points provided are only related to the company’s focus on the global Artificial Intelligence (AI) in drug discovery market.
0
id=3411&type=smp The global artificial intelligence in drug discovery market size is expected to grow from $0. com/report/artificial-intelligence-in-drug-discovery-global-market-report The Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022-31 by The Business Research Company evaluates artificial intelligence in drug discovery market size, growth rate, drivers, artificial intelligence in drug discovery industry trends, and major companies. Impact Of COVID-19 On Artificial Intelligence (AI) In Drug Discovery Market5. Key Mergers And Acquisitions Of The Artificial Intelligence (AI) In Drug Discovery Market 29. Future Outlook and Potential Analysis Of The Artificial Intelligence (AI) In Drug Discovery Market About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.
0
The global Drug Discovery Technologies Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2022-2028. Get more information on "Global Drug Discovery Technologies Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Drug Discovery Technologies Market Research Report with detailed TOC at https://www. By Technology Type· High Throughput Screening· Genomics· Biochips· Pharmacogenomics· Bioanalytical Instruments· Bioinformatics· Nanotechnology· Others (RNAi, Combinatorial Chemistry)By End User· Pharmaceutical Companies· Biopharmaceutical Companies· Biotech Companies· Research InstitutesRegional AnalysisThis section covers the regional outlook, which accentuates current and future demand for the Drug Discovery Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Purchase Complete Global Drug Discovery Technologies Market Research Report at https://www.
0
has added a new report titled, ‘Artificial Intelligence ( AI ) in Drug Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecasts, 2022 - 2027’ to its vast repository of research reports. The global Artificial Intelligence ( AI ) in Drug Discovery market was estimated at USD 0. Companies covered:Some of the key players in AI in Drug Discovery Market are Microsoft Corporation (US), Exscientia (UK), NVIDIA Corporation (US), Schrödinger (US), Atomwise, Inc. id=151193446The study categorizes the AI in drug discovery market into the following segments and subsegments:AI in drug discovery market, By Offering· Software· ServicesAI in drug discovery market, By Technology· Machine Learning· Deep Learning· Supervised Learning· Reinforcement Learning· Unsupervised Learning· Other Machine Learning Technologies· Other TechnologiesAI in drug discovery market, by Application· Immuno-oncology· Neurodegenerative diseases· Cardiovascular diseases· Metabolic diseases· Other ApplicationsAI in drug discovery market, By End User· Pharmaceutical & biotechnology companies· Contract research organizations· Research centers and academic & government institutesSome of the key geographies mentioned in this report include:· North America (U. S and Canada and rest of North America)· Europe (Germany, France, Italy, and Rest of Europe)· Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)· LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)Key questions answered in the report· What will be the market size and growth rate by the end of the forecast period?
0
While deepening AI penetration has been unlocking opportunities in disease diagnosis, and treatment, it has also been clearing its way in drug discovery. Fairfield Market Research intends to analyse the growth prospects of the application of AI for drug discovery and estimates the global revenue of the same to reach beyond US$1. While this reveals a drastically reduced time frame involved in the application of AI for drug discovery, there has been a constantly growing series funding in this market over the recent past. Venture capitalists are also stepping into the game, which is further uplifting the growth prospects of global market. Europe will follow with growing adoption of AI in healthcare and drug discovery.
0
Learn More On The Artificial Intelligence (AI) In Drug Discovery Market:https://www. The artificial intelligence (ai) in drug discovery market size is expected to see exponential growth in the next few years. The growing demand for personalized medicine is expected to propel the growth of the artificial intelligence (AI) in drug discovery market going forward. Thus, the growing demand for personalized medicine is driving the growth of the artificial intelligence (AI) in drug discovery market. The artificial intelligence (ai) in drug discovery market report table of contents includes:1.
0
